Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-35

First 35 Last

Share
Profile

Follow
FAnotTA

4,367 Posts.

587

25/10/23

16:25

Post #: 70533994
Share

Originally posted by Grainofsand: ↑

I have both (and only) Zeeshan and Justme53 on IGNORE, so I can't see which one you're responding too, but I might chime in to your comment and say I agree with you 100%. BOT is now FUNDAMENTALLY a better proposition than it was when previously running up to the last expected approval date. The science is now accepted by the FDA, whereas last time when it climbed from 5 to 21c (in the 7 months prior to the Sep decision), there was still room for doubt. Now that doubt has been completely removed by the CR Letter. If anything, the potential to exceed 21c prior to the approval is quite possible because we will begin climbing from a higher base this time (12-13c instead of 5c). The FUNDAMENTALS of this product going to sales once approval is granted (presently just held up for some labelling changes) remain unchanged. Just as the SP soared more than 300% leading up to anticipated approval in September, it would be ludicrous to suggest BOT won't move forward until 'after' approval this time around. Just nonsense. If it was worth 21c before last anticipated approval you can guarantee we'll be up in that territory again prior to approval before July 2024. For me, the only question is when will that climb toward approval begin again - I'm suspecting in the new year but maybe with some clarity around the FDA meeting in a week or so, followed by further good results of Japan's SB sales, it may start earlier. But my eye is on the long term price, so I'm pretty chillaxed about where it sits now and even anytime prior to approval.

Expand

GOS, we'll need to put asx on ignore too. Just keep repeating like a broken parrot and fawns over the downramper. Has no clue!!
2 Upvote

1 Great analysis

Reply

Top Stories

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PNN

Power gets set for 1000-metre maiden drilling program in Brazil

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

US election outcomes: Key economic and market takeaways

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

First 35 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 31.5¢		Change -0.005(1.56%)		Mkt cap ! $572.5M

Open	High	Low	Value	Volume
32.0¢	32.0¢	31.0¢	$1.366M	4.341M

Buyers (Bids)

No.	Vol.	Price($)
18	342765	31.0¢

Sellers (Offers)

Price($)	Vol.	No.
32.0¢	723414	18

View Market Depth

No.	Vol.	Price($)
16	336540	0.310
11	232799	0.305
36	572352	0.300
6	120637	0.295
7	148067	0.290

Price($)	Vol.	No.
0.320	623414	17
0.325	258370	4
0.330	119269	6
0.335	330000	3
0.340	409590	4

Last trade - 16.10pm 18/11/2024 (20 minute delay)

BOT (ASX) Chart

Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-35

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Power gets set for 1000-metre maiden drilling program in Brazil

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

US election outcomes: Key economic and market takeaways

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-35

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Power gets set for 1000-metre maiden drilling program in Brazil

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

US election outcomes: Key economic and market takeaways

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News